dc.contributor.author | Grinde, Maria Tunset | |
dc.contributor.author | Hilmarsdòttir, Bylgja | |
dc.contributor.author | Tunset, Hanna Maja | |
dc.contributor.author | Henriksen, Ida Marie | |
dc.contributor.author | Kim, Jana | |
dc.contributor.author | Haugen, Mads Haugland | |
dc.contributor.author | Rye, Morten Beck | |
dc.contributor.author | Mælandsmo, Gunhild Mari | |
dc.contributor.author | Moestue, Siver Andreas | |
dc.date.accessioned | 2019-08-29T06:27:30Z | |
dc.date.available | 2019-08-29T06:27:30Z | |
dc.date.created | 2019-04-23T10:01:02Z | |
dc.date.issued | 2019 | |
dc.identifier.citation | Grinde, M. T., Hilmarsdòttir, B., Tunset, H. M., Henriksen, I. M., Kim, J., Haugen, M. H., Rye, M. B., Mælandsmo, G. M. & Moestue, S. A. (2019). Glutamine to proline conversion is associated with response to glutaminase inhibition in breast cancer. Breast Cancer Research, 21: 61. doi: | nb_NO |
dc.identifier.issn | 1465-542X | |
dc.identifier.uri | http://hdl.handle.net/11250/2611489 | |
dc.language.iso | eng | nb_NO |
dc.publisher | BMC | nb_NO |
dc.rights | Navngivelse 4.0 Internasjonal | * |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/deed.no | * |
dc.title | Glutamine to proline conversion is associated with response to glutaminase inhibition in breast cancer | nb_NO |
dc.type | Journal article | nb_NO |
dc.type | Peer reviewed | nb_NO |
dc.description.version | publishedVersion | nb_NO |
dc.rights.holder | © 2019 The Author(s) | nb_NO |
dc.subject.nsi | VDP::Medisinske Fag: 700::Klinisk medisinske fag: 750::Gynekologi og obstetrikk: 756 | nb_NO |
dc.subject.nsi | VDP::Medisinske Fag: 700::Klinisk medisinske fag: 750::Onkologi: 762 | nb_NO |
dc.source.pagenumber | 13 | nb_NO |
dc.source.volume | 21 | nb_NO |
dc.source.journal | Breast Cancer Research | nb_NO |
dc.identifier.doi | 10.1186/s13058-019-1141-0 | |
dc.identifier.cristin | 1693367 | |
dc.relation.project | Kreftforeningen: 90393200 | nb_NO |
dc.relation.project | Norges forskningsråd: 239940 | nb_NO |